z-logo
open-access-imgOpen Access
Should the Food and Drug Administration Limit Placebo-Controlled Trials?
Author(s) -
Max Goodman,
Connor Pedersen
Publication year - 2022
Publication title -
voices in bioethics
Language(s) - English
Resource type - Journals
ISSN - 2691-4875
DOI - 10.52214/vib.v8i.9639
Subject(s) - food and drug administration , placebo , drug , limit (mathematics) , medicine , administration (probate law) , drug administration , drug trial , pharmacology , clinical trial , alternative medicine , mathematics , political science , mathematical analysis , pathology , law

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom